Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorColumbia University

About this trial

The rotator cuff is a set of muscles and tendons that help move the shoulder. Tears in the rotator cuff are common, particularly as people age. Consequently, rotator cuff repair surgeries are common, as well. Despite the frequency with which rotator cuff repairs are performed, there remains a high rate of postoperative failure to heal. In such situations, there is a lack of connective tissue establishment between the rotator cuff tendon and the bone. One strategy to attempt to improve healing of the rotator cuff tendon back to the bone is via the use of extracellular matrix allograft. This treatment is composed of tissue from other humans, which is stripped of its cells so that just the scaffolding around the cells remains. This decellularized scaffolding can be placed at the rotator cuff healing site in an attempt to augment healing. Both animal studies and human studies have shown promise with this approach. Of those patients enrolling in the study, 50% will be assigned at random to receive a standard rotator cuff repair AND allograft treatment, while 50% will be assigned at random to receive standard rotator cuff repair WITHOUT allograft treatment. All patients enrolled in the study will also obtain an MRI at one year following surgery in order to assess tendon healing. Of note, one-year postoperative MRIs are not standard following rotator cuff repair - only those enrolled in the study will receive this MRI. There will be no financial consequence of receiving this MRI.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age ≥ 18 years

Diagnosis of full thickness rotator cuff tear

Disqualifiers

Partial thickness tears

Full thickness subscapularis tears

Goutallier grades 3 and 4

Prior rotator cuff surgery

Trial design

Design model

Parallel

Treatments tested in this trial

  • Rotator Cuff Repair with Allograft Patch

    Other intervention

    Rotator cuff repairs will be augmented with use of a decellularized human placental allograft patch

  • Rotator Cuff Repair with No Augmentation

    Other intervention

    Standard rotator cuff repair with no augmentation

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Treatment ArmExperimental treatment 1 intervention
Group B: Control ArmOther 1 intervention

Trial outcomes

Primary outcomes

1

Retear Rate

The primary outcome measure will be the postoperative retear rate, measured on one-year postoperative MRI

Time frame
1 year

Secondary outcomes

1

Tendon Structural Continuity (MRI)

MRI Measurement of Tendon Structural Continuity

Time frame
1 year
2

Tendon Thickness (MRI)

MRI measurement of tendon thickness

Time frame
1 year
3

Constant-Murley score

The Constant-Murley score is a 100-point scale used to assess shoulder function, with a higher score indicating better function. The components include Pain (0 - 15 points), Activities of Daily Living (0 - 20 points), Range of Motion (0 - 40 points), and Strength (0 -25 points). The full score range is 0 to 100.

Time frame
1 year
4

American Shoulder and Elbow Surgeons (ASES) score

The American Shoulder and Elbow Surgeons (ASES) score is a patient-reported assessment of shoulder pain and function. It ranges from 0 to 100, with higher scores indicating better function. The ASES score combines a pain component (assessed using a Visual Analogue Scale (VAS) that ranges from 0 - 50) and a functional component (10 items, 5 points each). The full score range is 0 to 100.

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Columbia University

Lead sponsor

CTM Biomedical

Collaborator

This trial is not recruiting at the moment. You can still explore other options: